3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
11
Sarcoma
3
Lymphoid
2
Genitourinary
2
Other hematologic neoplasm
1
Gastrointestinal
1
Endocrine
1
Conditions
Pancreatic Neoplasms
6
Stomach Neoplasms
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Multiple Myeloma
2
Liver Neoplasms
2
Hepatoblastoma
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Wilms Tumor
1
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Thrombocytosis
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Penile Neoplasms
1
Ototoxicity
1
Neuroblastoma
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
Interventions
X-Rays
7
Specimen Handling
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
6
Nuclear Medicine Department, Hospital
5
Cyclophosphamide
5
fludarabine
4
Temozolomide
4
Carboplatin
4
Biopsy
4
Oxaliplatin
3
Nivolumab
3
Melphalan
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vemurafenib
2
Topotecan
2
Thiotepa
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Vorinostat
×
Gastrointestinal
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled